| Q0.50 |  | Q0.75 |  |
---|---|---|---|---|
 | Days | P-value | Days | P-value |
Intercept | 7.28 | 0.89 | 15 | 0.08 |
Age at diagnosis | ||||
 < 50 | 2.33 | 0.5 | −0.96 | 0.92 |
 50–59 | 4.85 | 0.09 | 3.39 | 0.58 |
 60–69 | 0 | . | 0 | . |
 70–79 | 5 | 0.0425 | 8.59 | 0.17 |
 ≥ 80 | 14.27 | 0.0001 | 34.28 | 0.0003 |
Residential Zones | ||||
 Calgary | 0 | . | 0 | . |
 Central | 3.18 | 0.33 | 9.23 | 0.25 |
 Edmonton | −0.62 | 0.81 | 1.13 | 0.85 |
 North | 0.98 | 0.79 | 8.67 | 0.44 |
 South | −7.15 | 0.0189 | −15.33 | 0.0455 |
Anatomic site | ||||
 Colon | 6.47 | 0.0014 | 9.56 | 0.0536 |
 Rectum | 0 | . |  |  |
Stage at diagnosis | ||||
 I | 25.67 | <.0001 | 42.13 | <.0001 |
 II | 8.47 | 0.0013 | 14.03 | 0.031 |
 III | 11 | <.0001 | 23.98 | 0.0001 |
 IV | 0 | . | 0 | . |
Charlson Comorbidity Score | ||||
 0 | 0 | . | 0 | . |
 1 | 5.13 | 0.0371 | 19.21 | 0.0025 |
 ≥ 2 | 31.86 | <.0001 | 82.24 | <.0001 |
GI comorbidity | ||||
 No | 6.4 | 0.0014 | 29.18 | <.0001 |
 Yes | 0 | . | 0 | . |
Usual Provider Continuity | ||||
 < 3 primary care visits | 4.52 | 0.35 | 13.54 | 0.39 |
 Low < =50% | 5.47 | 0.07 | 18.34 | 0.0046 |
 Medium 5080% | 4.87 | 0.06 | 11.64 | 0.0269 |
 High >80% | 0 | . | 0 | . |
# of GP visits | ||||
 0–1 | 0 | . | 0 | . |
 2 | 44.13 | <.0001 | 91.45 | <.0001 |
 ≥ 3 | 140.8 | <.0001 | 201.59 | <.0001 |
# of GI specialist visits | ||||
 0 | 0 | . | 0 | . |
 1 | 33.46 | <.0001 | 50.68 | <.0001 |
 ≥ 2 | 108.54 | <.0001 | 153.56 | <.0001 |
# of non-GI specialist visits | ||||
 0 | 0 | . | 0 | . |
 ≥ 1 | 81.55 | <.0001 | 101.56 | <.0001 |
# of endoscopy | ||||
 0 | 17.44 | <.0001 | 52.66 | <.0001 |
 1 | 0 | . | 0 | . |
 ≥ 2 | 36.05 | <.0001 | 50.43 | <.0001 |